Prime Medicine
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $315M
Investors
- 12
About Prime Medicine
Founded in 2019 and based in Massachusetts, US, Prime Medicine, Inc. operates as a developer of novel gene-editing technology solutions that can cure and prevent genetic diseases. The company was co-founded by David R.D. In May 2024, Alphabet, a portfolio company of The Google LLC, acquired Prime Medicine Inc. As of 2025 the company is headed by its CEO Allan Reine. The company offers a next-generation technology called Prime Editing, that can search and replace to restore normal gene function and address the fundamental causes of disease and treat diseases that benefit patients.
Who invested in Prime Medicine
12 investors across 2 rounds
See all investors in Prime Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prime Medicine
Who invested in Prime Medicine?
Prime Medicine has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prime Medicine raised?
Prime Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prime Medicine last raise money?
Prime Medicine's most recent round on record is a Series B, in Jul 2021.
What does Prime Medicine do?
Founded in 2019 and based in Massachusetts, US, Prime Medicine, Inc.
Where is Prime Medicine headquartered?
Prime Medicine is headquartered in Cambridge, US.
Which VCs invest in companies like Prime Medicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Prime Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Prime Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.